3 Best Oncologists in Denver, CO

Here’s The Deal:
Dr. Daniel Donato is a well-experienced gynecologic oncologist who graduated from the University of Miami Medical School, Miami, FL and completed his residency at the Jackson Memorial Hospital/the University of Miami, Miami, FL. He did his gynecologic oncology fellowship at the Jackson Memorial Hospital/the University of Miami, Miami, FL. Dr. Daniel Donato is board-certified in gynecologic oncology and obstetrics-gynecology. He strives to make his patient's experience as comfortable and positive as possible, and he firmly believes in listening to his patients and supporting their decisions wholeheartedly. Dr. Daniel Donato surgical expertise includes traditional surgical techniques and extensive experience with robotic-assisted surgeries. He works closely with medical oncologists, radiation oncologists, and other sub-specialists partnering to care for cancer treatment patients.

Here’s The Deal:
Dr. Dev Paul is a prominent board-certified medical oncologist with advanced subspecialty expertise in breast cancer. He graduated from Michigan State University and finished his internal medicine residency at the University of Wisconsin, Madison, WI. Dr. Paul practices evidence-based medicine and follows National Comprehensive Cancer Network (NCCN) guidelines. He specializes in treating breast cancer, and he focuses on delivering palliative care, the use of pain medication to make a dying person more comfortable. Dr. Dev develops customized cancer treatment plans for each patient, incorporating cutting-edge therapies. Dr. Dev Paul is now practicing at Rocky Mountain Cancer Centers, which confers comprehensive cancer care to patients and their families.

Here’s The Deal:
Dr. Allen L. Cohn is one of the leading medical oncologists in Denver, CO. He is a board-certified medical oncologist with advanced subspecialty expertise in gastrointestinal and genitourinary cancers. Dr. Allen employs cutting-edge cancer treatments such as chemotherapy, immunotherapy, targeted therapy, hormone therapy, and clinical trials. He practices evidence-based medicine and follows National Comprehensive Cancer Network (NCCN) guidelines. Dr. Allen serves as the Medical Director of Research for RMCC. RMCC is part of the US Oncology Network, one of the most extensive research programs in the country. The network draws from over 1,380 experienced physicians and dedicated clinical staff specializing in oncology clinical trials, enrolling more than 82,000 patients in over 1,600 trials and playing a role in over 100 FDA-approved cancer therapies in the past 20 years.